Ethical Review of Research

1. Full Board Review

Sterling IRB typically convenes daily panels (Monday-Friday) to review the ethical considerations associated with new and continuing research studies. Please see the Board Meeting Calendar for specific meeting dates.

New studies and changes in Sterling IRB-approved research should be submitted by our secure web portal, email, fax or mail and received by Sterling IRB at least 5 business days prior to a scheduled IRB meeting.

Please note: The Sterling IRB administrative staff works closely with clients to meet deadlines, particularly those that do not fall within the usual study submission timeline. Our staff makes every effort to resolve any questions or concerns prior to the Board meeting to ensure a timely review process.

Sterling IRB will contact the Sponsor/CRO and/or Principal Investigator within 24 hours of the meeting with notification of the Board's decision. Documents posted to SilverLink within 24 - 48 hours of approval.

2. Expedited Review

Pursuant to US Food and Drug Administration (FDA) regulations and US Department of Health and Human Services (DHHS) regulations, Sterling IRB employs the expedited review procedure for minor changes in previously approved research and for initial review of studies in permissible categories as detailed in the Federal Register.

The investigator and Sponsor will be notified in writing of the Primary Reviewer's determination.

Documents posted to SilverLink within 24 - 48 hours of approval.

To learn more or if you have any questions, call 1-888-636-1062 (toll-free) or This email address is being protected from spambots. You need JavaScript enabled to view it. .



Innovation. Passion. Commitment. We believe these are the essential components of strong teamwork.



A diverse group of scientific and non-scientific members with nearly a century of collective IRB experience.



Sterling IRB has formed a strategic partnership with Veritas IRB.

©2014 Sterling IRB. All rights reserved.